Kyverna Therapeutics Congratulates Scientific Advisory Board Member Peter A. Merkel, M.D., M.P.H. on Receiving the 2023 ACR Distinguished Clinical Investigator Award

Dr. Merkel will receive the award during the 2023 ACR Convergence Meeting in San Diego, CA for his outstanding contributions to the field of rheumatology EMERYVILLE, Calif., Nov. 11, 2023 /PRNewswire/ — Kyverna Therapeutics, Inc. (Kyverna), a patient-centered clinical-stage…

Click here to view original post